Difference between revisions of "Phosphtase Subfamily CDC25"
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
| − | [[Phosphatase classification|Phosphatase Classification]]: [[Phosphatase_Superfamily_CC3|Superfamily CC3 ( | + | [[Phosphatase classification|Phosphatase Classification]]: [[Phosphatase_Superfamily_CC3|Superfamily CC3 (Rhodanese)]]: [[Phosphatase_Family_CDC25|Family CDC25]]: [[Phosphatse_Subfamily_CDC25|Subfamily CDC25]] |
CDC25 subfamily has three member genes in human, '''[[Gene_CDC25A|CDC25A]]''', '''[[Gene_CDC25B|CDC25B]]''', '''[[Gene_CDC25C|CDC25C]]'''. They contain a catalytic domain on the C-terminus <cite>fauman98 reynolds99</cite>, and a less-conserved N-terminal regulatory region <cite>forrest01</cite>, which can be phosphorylated and ubiquitinated. CDC25 activates cyclin-dependent kinases ([http://kinase.com/wiki/index.php/Kinase_Family_CDK CDKs]) by dephosphorylating two sites within their ATP binding loop. CDKs regulate key transitions between cell cycle phases, and are key components of the checkpoint pathways involved in DNA damage. Thus, it is not suppressing to find it overexpressed in many human cancers <cite>Boutros07</cite>. | CDC25 subfamily has three member genes in human, '''[[Gene_CDC25A|CDC25A]]''', '''[[Gene_CDC25B|CDC25B]]''', '''[[Gene_CDC25C|CDC25C]]'''. They contain a catalytic domain on the C-terminus <cite>fauman98 reynolds99</cite>, and a less-conserved N-terminal regulatory region <cite>forrest01</cite>, which can be phosphorylated and ubiquitinated. CDC25 activates cyclin-dependent kinases ([http://kinase.com/wiki/index.php/Kinase_Family_CDK CDKs]) by dephosphorylating two sites within their ATP binding loop. CDKs regulate key transitions between cell cycle phases, and are key components of the checkpoint pathways involved in DNA damage. Thus, it is not suppressing to find it overexpressed in many human cancers <cite>Boutros07</cite>. | ||
Latest revision as of 01:48, 23 August 2015
Phosphatase Classification: Superfamily CC3 (Rhodanese): Family CDC25: Subfamily CDC25
CDC25 subfamily has three member genes in human, CDC25A, CDC25B, CDC25C. They contain a catalytic domain on the C-terminus [1, 2], and a less-conserved N-terminal regulatory region [3], which can be phosphorylated and ubiquitinated. CDC25 activates cyclin-dependent kinases (CDKs) by dephosphorylating two sites within their ATP binding loop. CDKs regulate key transitions between cell cycle phases, and are key components of the checkpoint pathways involved in DNA damage. Thus, it is not suppressing to find it overexpressed in many human cancers [4].
CDC25 is found in most animals, but is absent from land plants and green alga Chalmydomonas. In excavates, they are found in Trichomonas, but not Giardia, Leishmania, or Trypanosomes.
References
- Fauman EB, Cogswell JP, Lovejoy B, Rocque WJ, Holmes W, Montana VG, Piwnica-Worms H, Rink MJ, and Saper MA. Crystal structure of the catalytic domain of the human cell cycle control phosphatase, Cdc25A. Cell. 1998 May 15;93(4):617-25. DOI:10.1016/s0092-8674(00)81190-3 |
- Reynolds RA, Yem AW, Wolfe CL, Deibel MR Jr, Chidester CG, and Watenpaugh KD. Crystal structure of the catalytic subunit of Cdc25B required for G2/M phase transition of the cell cycle. J Mol Biol. 1999 Oct 29;293(3):559-68. DOI:10.1006/jmbi.1999.3168 |
- Forrest A and Gabrielli B. Cdc25B activity is regulated by 14-3-3. Oncogene. 2001 Jul 19;20(32):4393-401. DOI:10.1038/sj.onc.1204574 |
- Boutros R, Lobjois V, and Ducommun B. CDC25 phosphatases in cancer cells: key players? Good targets?. Nat Rev Cancer. 2007 Jul;7(7):495-507. DOI:10.1038/nrc2169 |
